IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pseudo Biologist who wrote (513)	3/24/1997 8:05:00 PM
From: I. Luttichuys	of 1762

Thanks Max, Although I have been a relative long-time IDEC shareholder I have not kept up in the area of their anti-gp39 work. I do recall reading something about it and this may have been from the prospectus as, the contents of you post strikes me as especially familiar. I believe I am remember the part about the animal model's immune system returning to normal after treatments but with continuing supression of disease. This must have struck me as I remember now the reference to this therapy. IDEC performed well today in what was an initially down market. I have been looking at the December 25 calls and wonder what you are anyone reading this might think of these. The ask is seven at this point. With IDEC showing the staying power that it has in this market, I am thinking that we may have another rally, especially if Merrill Lynch initiates coverage on IDEC as I expect they will... Thank you, BENNETT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next